Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.
about
Circulating tumors cells as biomarkers: progress toward biomarker qualificationProgress in circulating tumor cell capture and analysis: implications for cancer managementMesenchymal phenotype of CTC-enriched blood fraction and lymph node metastasis formation potential.Prognostic and predictive biomarkers: tools in personalized oncology.Circulating tumor cells: from bench to bedsideEfficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer.Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer.Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis.The expression of CK-19 gene in circulating tumor cells of blood samples of metastatic breast cancer women.Expression and Clinical Significance of Cytokeratin-19 and Thymidine Kinase-1 in Advanced Gastrointestinal Cancer.Clinical implications of the detection of circulating tumor cells in breast cancer patients.Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment.Advanced technologies for studying circulating tumor cells at the protein level.Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.Gene expression profiling and DNA methylation analyses of CTCs.Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.Circulating tumour cells in breast cancer.Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.Upregulation of human mammaglobin reduces migration and invasion of breast cancer cells.Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells.Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.Classifying circulating tumor cells to monitor cancer progression.Prognostic role of plasma mammaglobin A expression in breast carcinoma patients: a meta-analysis.Clinical application of circulating tumor cells in breast cancer
P2860
Q26852579-E8898A95-18C5-4DD4-99EC-5F3F6B73D4BCQ27025737-1B5F729A-4436-4252-9BD6-BD2FEF646C3FQ31158116-D545AA1B-70B8-4916-B0A9-5B6FA399B6D6Q33651583-AD9E2CBC-5118-422A-9B57-166261245BC7Q34307782-3791ECC5-EEB6-47F5-8A12-DAFB25E3069CQ35665814-400A690B-3018-460D-BD49-1EB05DF3E3EFQ36072794-C634FB7C-61A7-4EDA-81A3-26C85C09962DQ36083213-3A21FF8C-AB6B-4ECE-9E5C-B63931AA5AEEQ36321612-904E142E-538A-4C28-8390-64E69C07CDDCQ36423754-53CF7F87-C85A-4A83-8A7E-A07DEC0FEF53Q37254986-5742DF20-C1AA-42F8-B835-2886AA60575FQ37980500-3B9AC330-A8AD-4634-AB5B-079F9B22A333Q38018253-7B666C6B-FE1E-4D40-B476-47CA5344462DQ38160932-7028473E-FB65-4462-8DF7-345A8F75517AQ38547813-E1B592BD-68BE-456C-945F-E66607E6F0B0Q38734877-7AD75760-01C3-4603-A47E-90609321A202Q41603225-A094380B-CB42-43E0-B950-56D16D3D22F0Q42633641-67FFCB56-645E-4813-AD80-63BE87773E1EQ44396376-9A8E1A2D-E871-461A-8E46-353E983A7F6DQ44421418-3B3EEB13-9A96-461B-B0C0-A2534854E1AFQ44623341-4ACC25E6-E9DB-4858-B040-F3B77A3F27ABQ47109529-33364D86-A2E8-4936-A757-8B1435D5863DQ50199981-087BDA84-854D-424D-874C-1195E389BD92Q53755908-9451E082-59BD-4A23-B43E-7F0C2D72BE50Q54974366-B1B3AF23-776B-4963-A0F0-C5E09CB96DACQ57129057-B46FC68D-C2A7-400A-8DDF-39E4793B67E9
P2860
Cytokeratin-19 and mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Cytokeratin-19 and mammaglobin ...... oup trials, N0234/336/436/437.
@en
Cytokeratin-19 and mammaglobin ...... oup trials, N0234/336/436/437.
@nl
type
label
Cytokeratin-19 and mammaglobin ...... oup trials, N0234/336/436/437.
@en
Cytokeratin-19 and mammaglobin ...... oup trials, N0234/336/436/437.
@nl
prefLabel
Cytokeratin-19 and mammaglobin ...... oup trials, N0234/336/436/437.
@en
Cytokeratin-19 and mammaglobin ...... oup trials, N0234/336/436/437.
@nl
P2093
P2860
P1476
Cytokeratin-19 and mammaglobin ...... roup trials, N0234/336/436/437
@en
P2093
Alvaro Moreno-Aspitia
Betsy LaPlant
David Hillman
Donald W Northfelt
Edith A Perez
Jake B Allred
Kathleen A Kitzmann
Kathleen Tenner
Monica M Reinholz
Philip J Stella
P2860
P304
P356
10.1158/1078-0432.CCR-11-0981
P407
P50
P577
2011-10-05T00:00:00Z